ABSTRACT
INTRODUCTION
Non-invasive hemodynamic monitors have been used in critically ill and high-risk surgical patients; however, their use in an obstetric population is rare [1] [2] [3] . Given their non-invasive nature and lack of ionizing radiation, they have an obvious advantage over their invasive counterparts. The invasive nature of thermodilution techniques utilizing a pulmonary artery catheter, as well as the associated risks of vascular injury, infection and cardiac arrhythmias 4 , render invasive monitoring in pregnancy an almost obsolete practice, reserved only for critical cases. There is a need for non-invasive hemodynamic monitoring in pregnant women, for both research and clinical purposes.
A number of non-invasive cardiac output (CO) devices are commercially available. The device used in this study was USCOM-1A ® (ultrasound cardiac output monitor, USCOM Ltd, NSW, Australia). Several validation studies of USCOM-1A have been published in non-obstetric and obstetric populations [5] [6] [7] [8] . Our group conducted a cross comparison study and reported good agreement (mean percentage difference < 30%) between USCOM-1A and two-dimensional transthoracic echocardiography in advanced pregnancy 9 . In order to enable clinical application and further research using this methodology, it is imperative that device-specific reference ranges for an obstetric population are available. Furthermore, there is a need to investigate whether maternal central hemodynamic variables, such as stroke volume (SV), CO and systemic vascular resistance (SVR), are influenced by maternal characteristics such as age, height and weight.
The main aim of this study was to construct reference ranges of maternal central hemodynamic parameters during pregnancy. The second aim was to determine the maternal and pregnancy characteristics that influence these hemodynamic parameters.
METHODS
This was a prospective cohort study in low-risk pregnant women attending a tertiary referral hospital between September 2012 and May 2016. Inclusion criteria were women with an uncomplicated singleton pregnancy between 10 and 40 weeks' gestation attending antenatal care at St George's Hospital, London, UK. Exclusion criteria included any medical disorder present at the time of study recruitment, or development of hypertension or intrauterine fetal growth restriction following study recruitment. Pregnancies complicated by major fetal anomalies, aneuploidy, intrauterine fetal demise or those undergoing termination of pregnancy were excluded.
Written consent was obtained from all study participants and local research ethics committee approval (12/LO/0810) was obtained prior to data collection. All women were examined by their midwives or obstetricians, and both maternal and fetal wellbeing were confirmed prior to hemodynamic assessment. Gestational age (GA) was calculated from crown-rump length measured at 11-13 weeks' gestation or head circumference if the first ultrasound scan was performed after 14 weeks.
Maternal history and characteristics
Women who agreed to participate were invited to complete a questionnaire stating their age, ethnic origin (Caucasian, Afro-Caribbean, South Asian, East Asian, Mixed/Other), method of conception (spontaneous, assisted), smoking during pregnancy (yes/no), history of chronic hypertension (yes/no), medication history and medical/obstetric history. The history and questionnaire were then reviewed by the study investigators to verify eligibility of the subjects to be included in the study, maternal height and weight were measured and body mass index (BMI) at examination was calculated. Maternal weight and BMI at pregnancy booking were also recorded.
Hemodynamic assessment
USCOM-1A measurements were performed under standardized conditions for the entire cohort. The study subjects had a single hemodynamic assessment performed at study recruitment. Measurements were obtained with the patient in a semirecumbent position. USCOM-1A employs continuous-wave Doppler, with a non-imaging probe in the suprasternal notch to obtain velocity time integrals (VTI) of transaortic blood flow at the left ventricular outflow tract (LVOT). Using an anthropometric algorithm, which correlates the outflow tract diameter with the patient's height 10 , USCOM-1A uses the VTIs to compute the hemodynamic parameters. The three variables of interest in this study were SV, CO and SVR.
Statistical analysis
Models were fitted using the GAMLSS package for R (R Foundation, Vienna, Austria) 11 . Improvements in model fit were evaluated using the generalized likelihood ratio test, with statistical significance set at P < 0.05. For each hemodynamic variable, a normal distribution with mean conditional on GA was considered first. The relationship between mean and GA was flexibly modeled using a natural cubic spline (NCS) basis with boundary knots at the 10 th and 90 th centiles (87.6 and 266 days, respectively) and internal knots at the 30 th , 50 th and 70 th centiles (152, 210 and 252 days, respectively). The SD was then also allowed to vary with GA, with the same boundary knots but with an internal knot at only the 50 th centile. The model was then extended in each case to allow for a skewed distribution using the Box-Cox, Cole and Green (BCCG) distribution, and then to also adjust for the kurtosis (or 'tailedness') of the data using the Box-Cox power exponential distribution (BCPE) 12 . For the BCCG and BCPE distributions, the median and scale parameter were modeled as smooth functions of GA using NCS, as were the mean and SD for the normal distribution, and the skewness and kurtosis parameters were estimated as constants. Plots of standardized residuals were checked.
Once the distribution of the data had been determined with respect to GA, patient characteristics that might plausibly be associated with the hemodynamic variables were added to the model to see whether they provided a significant improvement in the prediction of the mean/median value. Maternal booking weight and height were added to the models first, each using a cubic spline basis with boundary knots at the 10 th and 90 th centiles and internal knots at the 50 th centiles (59.18, 96.58 and 74 kg, and 1.56, 1.73 and 1.64 m, respectively), and an interaction term (centered at the medians) was then added for weight and height. A constant effect of smoking during pregnancy was then tested, followed by the addition of maternal age using a NCS basis with boundary knots at the 10 th and 90 th centiles and an internal knot at the 50 th centile (24, 38 and 32 years, respectively). Finally, the effects of conception through assisted reproduction, nulliparity and ethnicity (Caucasian, Afro-Caribbean, South Asian, East Asian or mixed/other) were tested.
RESULTS
Maternal hemodynamic measurements were performed in 758 pregnancies. A total of 131 cases were excluded owing to maternal or fetal complications or recruitment to the study either before 10 or after 40 weeks' gestation. Therefore, 627 single measurements were included in the final analysis. Maternal baseline characteristics and pregnancy outcome data are summarized in Table 1 .
Reference ranges
The USCOM-1A-specific reference ranges, displaying the 5 th , 50 th and 95 th centiles for SV, CO and SVR, are shown in Figure 1 . The normal distribution was adequate to model SV, but the BCPE distribution provided an improvement in model fit for CO and SVR. Increasing median values of CO and SV were observed from 10 weeks until around 31 and 21 weeks, respectively, with a subsequent decrease until term for each variable. These changes were mirrored by a reduction in the median value of SVR from 10 weeks until around 32 weeks, followed by an increase towards term.
Associations with maternal characteristics

Cardiac output
Maternal weight (P < 0.001) and height (P < 0.001) significantly influenced the CO values, and there was a significant interaction (P = 0.002) between them ( Figure 2a ). In women with a height of less than 1.60 m, there was no association between median CO and maternal weight, but in those with a height exceeding 1.60 m, an increase in weight was associated with an increase in CO. Maternal age was also significantly associated with the median CO (P < 0.001). The estimated median CO was constant above the age of 32 years, but was around 0.5 L/min higher for women aged 25 or younger (Figure 3) . Smoking was not a statistically significant predictor (P = 0.07) once age had been added to the model, and so this was dropped from the model for analysis. No further significant improvements in model fit were gained by the addition of mode of conception (P = 0.11), parity (P = 0.14) or ethnicity (P = 0.13).
Stroke volume
Significant improvements in model fit for SV were achieved by the addition of maternal weight (P < 0.001), height (P < 0.001) and their interaction (P = 0.035). However, no further improvement to model fit was provided by smoking (P = 0.12), maternal age (P = 0.999), mode of conception (P = 0.25), parity (P = 0.43) or ethnicity (P = 0.19). SV was primarily associated with maternal height, although some positive association with weight could also be observed within the normal BMI range (Figure 2b ).
Systemic vascular resistance
Improvements in model fit for SVR were achieved by the addition of maternal height (P < 0.001), but not of maternal weight (P = 0.63). In addition, smoking A spreadsheet to calculate centile positions of USCOM-1A measurements dependent on either GA alone or on all significant predictors for each variable has been provided online (Appendix S1).
DISCUSSION
Summary of study findings
This study provides reference ranges for SV, CO and SVR obtained using USCOM-1A in uncomplicated, singleton pregnancies. We report a significant effect of maternal age, weight and height on CO, of maternal weight and height on SV and of maternal age, height and smoking status on SVR.
Comparison with existing literature
This is the largest study of maternal hemodynamics in a low-risk obstetric population using USCOM-1A. Kager et al. 13 reported on CO estimates in 172 patients across all trimesters of pregnancy, obtained using USCOM-1A. Currently there are no published device-specific reference ranges for USCOM-1A obtained in a large cohort of uncomplicated pregnancies. There are no reported studies of this scale that investigate the effects of various maternal characteristics on central hemodynamic variables in an obstetric cohort.
Clinical and research implications
Prior to the introduction of non-invasive maternal hemodynamic monitoring in clinical practice, it is imperative that methodology-specific reference ranges are established. Previous work investigating hemodynamics have been performed using thermodilution and echocardiography [14] [15] [16] [17] [18] [19] . These methods have significant drawbacks, including the invasive nature and the requirement of specialist training and expertise, respectively.
In the published literature, assessment of the performance of novel CO monitors against a reference method has been carried out using Bland-Altman analysis, which is the recommended method of statistical analysis when assessing two cardiac output devices 20 . A mean percentage difference of < 30% between two devices has been proposed as the level of clinical acceptability 21 . Previous investigations focused on assessing the adequacy of interchangeable use of the two methods, or on the potential replacement of one method by another. However, these aims can be questioned in the present setting. USCOM-1A, or any other similar device, will not replace thermodilution as the 'gold standard' method for CO estimation, and achieving a mean percentage difference of < 30% remains difficult to attain. Indeed many comparison studies evaluating USCOM against thermodilution have reported poor agreement (mean percentage difference > 30%) when assessed against thermodilution or echocardiography [5] [6] [7] [8] . However, the limitations of the reference methods used in the studies should be taken into account, as these do not provide an error-free measurement of CO. Instead, we propose that USCOM-1A would provide an alternative, non-invasive methodology enabling simple, bedside assessment of maternal hemodynamics. The benefits include excellent intraobserver repeatability and interobserver reproducibility 9, 13 , and the potential for the measurements to be obtained by healthcare professionals of all levels 22 . The relationships between maternal hemodynamic variables and patient characteristics reported in this study are novel. CO decreases with advancing maternal age until the age of 32, and SVR increases over a similar period. These findings are consistent with the inverse relationship observed between cardiac function and age, supporting the notion of increasing cardiovascular risk with advancing maternal age. Furthermore, the physiological consequence of a decrease in SVR in taller individuals will result in an increase in SV, as we report in this study.
Hypertensive disorders of pregnancy are associated with aberrations in maternal hemodynamics prior to the onset of clinical disease [23] [24] [25] [26] . Advancing maternal age is a recognized risk factor for hypertension in pregnancy 27 . The findings of increased SVR and decreased CO observed in our cohort lend further support to the observed association between advancing age and the risk of developing hypertension in pregnancy. Smoking is a known risk factor for cardiovascular disease, and is hazardous to fetal, child and maternal wellbeing [28] [29] [30] . However, maternal smoking does have a protective effect on the development of pre-eclampsia, which has been demonstrated in epidemiological and molecular studies [31] [32] [33] . Our reported finding of reduced SVR in smokers provides further central hemodynamic evidence for the protective role of smoking with respect to hypertension in pregnancy.
An unexpected finding was the lack of effect of maternal weight on SVR. Increasing maternal weight is a known risk factor for hypertension in pregnancy. We postulate that the most likely explanation for the lack of effect of maternal weight on SVR is that SVR is derived from mean arterial pressure and CO. Even though CO increases with weight, and should result in a decrease in SVR, mean arterial pressure also increases with weight. It would appear that these two cancel out, thereby explaining the lack of effect of maternal weight on SVR. Furthermore, the increase in blood pressure seen with increasing maternal weight is due to an increase in CO, which is independent of SVR. Previous work by our group has shown no difference in SVR between morbidly obese pregnant women and controls with normal BMI 34 . Future studies to assess the structural and functional myocardial changes (using echocardiography) associated with increased maternal weight and, more specifically, weight gain in pregnancy, are required to explore this.
Strengths and limitations of the study
This study included a large cohort of uncomplicated low-risk singleton pregnancies. All patients who developed hypertension in pregnancy after being recruited to the study were excluded from the analysis, therefore women with altered hemodynamic function prior to the onset of clinical disease were not included in the study. Furthermore, statistical modeling enabled the construction of reference ranges and assessment of the potential relationship between maternal characteristics and hemodynamics. Using a solitary hemodynamic assessment instead of multiple readings is a study limitation; one way to address this would be to perform multiple, serial measurements in a subject over a defined time period, which is the aim of an ongoing research study. We have previously reported excellent repeatability (intraclass correlation coefficient (ICC) 0.969 (95% CI, 0.953-0.980)) and reproducibility (ICC 0.896 (95% CI, 0.812-944)) of USCOM 9 . One recognized limitation of the methodology used in this study is the use of an inherent nomogram that estimates LVOT diameter from the patient's height. Any difference between the estimated and measured LVOT could be a source of potential bias. The bias resulting from this is a possible explanation for the difference in the relationship observed between CO and maternal height below and above 1.6 m. The authors recognize that a significant limitation of the methodology employed in this study is the poor agreement when assessed against invasive, reference methods in previously conducted comparison studies. A final study limitation is the lack of prepregnancy and early pregnancy data; however this is the focus of ongoing research.
Conclusions
This study reports SV, CO and SVR reference ranges obtained using USCOM-1A in uncomplicated singleton pregnancies. The interrelationships between these hemodynamic parameters and maternal characteristics are also demonstrated. The implications of the latter findings extend beyond pregnancy and are likely to influence the design and interpretation of future studies.
